Intestinal Obstruction Associated with Cholestyramine Therapy
- 5 June 1969
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 280 (23) , 1285-1286
- https://doi.org/10.1056/nejm196906052802307
Abstract
CHOLESTYRAMINE, a quaternary ammonium anion-exchange resin, has been used in the management of severe pruritus from obstructive jaundice1 and for hypercholesterolemia.2 This nonabsorbable resin binds bile salts in the gastrointestinal tract, thereby preventing normal terminal ileal reabsorption and enhancing fecal excretion. With complete biliary obstruction the drug is ineffective since only bile salts excreted through the intestinal epithelium can be bound. Cholestyramine has been efficacious in the management of so-called "intrahepatic biliary atresia," with relief of anorexia and pruritus, lowering of serum cholesterol and bilirubin, reduction in number and size of cutaneous xanthomas and improvement of liver function with the . . .Keywords
This publication has 3 references indexed in Scilit:
- Response of hyperlipoproteinemia to cholestyramine resinPublished by American Medical Association (AMA) ,1968
- Cholestyramine therapy in patients with a paucity of intrahepatic bile ductsThe Journal of Pediatrics, 1967
- Effect of an Anion Exchange Resin on Serum Cholesterol in Man.Experimental Biology and Medicine, 1959